CAChristine A. Arbour

Christine A. Arbour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christine A. Arbour has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A DMF-Free Large Scale Solid-Phase Synthesis of the Linear Precursor of Sunflower Trypsin Inhibitor-1 Guided by Sustainability Principles

    by Christine A. Arbour, Jessica A. Gudorf, Quibria A.E. Guthrie, Ryan W. Curtis, Shivani Choudhary, Patrick J. Jansen, Jacob A. Desmond, Mahmoud Elkhalifa, Ankur Jalan, Emily Murzinski Valco, et al.

    Solid-phase peptide synthesis (SPPS) at commercial scale depends on three substances now subject to tightening regulatory pressure: dimethylformamide (DMF), classified as a reprotoxic substance of very high concern under EU REACH; dichloromethane (DCM), broadly prohibited for industrial use in the United States under the 2024 EPA TSCA rule; and piperidine, a DEA Schedule I precursor requiring licensed handling and disposal at manufacturing scale. We report a 50 mmol, DMF-free synthesis of the linear precursor of sunflower trypsin inhibitor-1 (SFTI-1) that simultaneously eliminates all three substances from a pharmaceutically relevant Fmoc/tBu SPPS process without compromising yield, purity, or stereochemical integrity. DCM-free resin loading and swelling were achieved using 1:1 EtOAc/ACN; coupling and Fmoc deprotection were conducted in 1:1 NBP/EtOAc throughout, with 2% DBU replacing 20% piperidine — reducing deprotection base consumption by 91%. Operating at 1.5 equivalents of amino acid and coupling reagents vs the conventional 3.0 equivalents delivered a 50% reduction in stoichiometric inputs. The principal synthetic challenge, arginine coupling, was addressed through high-throughput experimentation identifying 2:3 DMSO/1,3-dioxolane at 40 °C as a greener solvent system achieving 97% conversion. Head-to-head comparison against a conventional DMF benchmark confirmed equivalent potency-corrected peptide output, comparable crude purity, and no increase in epimerization across all nine chiral residues. Collectively, these improvements delivered an estimated 9% reduction in total process mass intensity (PMI) relative to the DMF process (847 vs 934 kg/kg crude peptide), with the dominant gains concentrated in deprotection base and reagent stoichiometry. Normalized per amino acid to enable comparison with reported industry benchmarks, both the conventional (66.7 kg/kg per amino acid) and green (60.5 kg/kg per amino acid) variants of this process already operate roughly an order of magnitude below the average PMI reported for commercial-scale SPPS in a recent multicompany benchmarking analysis (874.5 kg/kg per amino acid) (J. Org. Chem. 2024, 89, 4261−4282). These results provide a compliance-ready, industrially validated framework for commercial SPPS under current and forthcoming regulatory constraints.


  • Open Access

    Glycoconjugate diversification in Campylobacter concisus is determined by two glycosyltransferases

    by Hayley L. Knox, Christine A. Arbour, Chaoshuang Xia, Catherine E. Costello, Barbara Imperiali, Karen N. Allen

    Bacterial glycoconjugates are structurally diverse, with enormous variation in sugar identity, modifications and linkages. Glycoconjugates play key roles in numerous cell functions, acting as the primary interface with the environment. Asparagine ( N )-linked glycosylation has been extensively studied in the pathogenic Campylobacter genus, due to the availability of numerous genome sequences and the highly conserved pathway logic, despite the final N -linked glycan product diversity. We recently reported on a partitioning of N -linked glycan structures between the Campylobacter species, focused on the inclusion of a C6-carboxyl-sugar in the third position of the growing glycan in Campylobacter concisus . However, at the time, the final glycan was not fully defined. Here, we identify the final glycan product in C. concisus , demonstrating surprising substrate promiscuity of the GT-A enzyme, PglI, which adds the penultimate sugar, and uncover a previously uncharacterized enzyme (GT-25) that unexpectedly adds the final sugar to complete the heptasaccharide product. Through a detailed study of these two C. concisus pathway enzymes, the intermediate and final glycans were defined, with determination of linkage positions of major and minor isomeric products following each glycan addition, through high-resolution electronic excitation dissociation tandem mass spectrometry. These findings on the Group II C. concisus N -linked glycan highlight the diversification of the glycan and the utilization, at the non-reducing end, of GlcNAc over GalNAc, which is dominant in the Group I species.

  • Open Access

    Correlating membrane‐protein dynamics with function: Integrating bioinformatics, molecular dynamics, and single‐molecule FRET

    by Hugh R. Higinbotham, Christine A. Arbour, Barbara Imperiali

    We present a strategy that deploys structural bioinformatics, molecular simulation, and single‐molecule Förster Resonance Energy Transfer (FRET) microscopy for observing the ligand‐dependent conformational dynamics of integral membrane proteins in situ. We focus on representative members of the small monotopic phosphoglycosyl transferase (SmPGT) superfamily, which catalyze the transfer of a phosphosugar from a soluble nucleotide‐sugar donor to a membrane‐embedded polyprenol phosphate acceptor in the initiating step of glycoconjugate biosynthesis in prokaryotes. Substrate‐specific structural features were identified across the superfamily and correlated with ligand‐dependent conformational dynamics in all‐atom simulations. To experimentally validate the role of this motion in ligand binding, we developed a platform to monitor intramolecular protein dynamics in a native‐like lipid environment. The presented approach incorporates selective cysteine protein labeling and non‐canonical amino acid mutagenesis with bicyclononyne‐tetrazine click chemistry to assemble dual‐labeled variants of PglC, the initiating enzyme of the N‐linked protein glycosylation pathway from the Campylobacter genus. The modified proteins are solubilized in styrene‐maleic acid liponanoparticles (SMALPs), which provide a model membrane environment. The conformational changes of PglC upon inhibitor binding correlate with inhibitor potency. The single‐molecule FRET‐SMALP strategy can be adapted to investigate protein dynamics across the superfamily of SmPGTs with different substrate selectivity, where structure prediction and molecular dynamics support significant conformational changes upon ligand binding.


  • Open Access

    Correlating membrane-protein dynamics with function: Integrating bioinformatics, molecular dynamics, and single-molecule FRET

    by Hugh R. Higinbotham, Christine A. Arbour, Barbara Imperiali

    We present a strategy that deploys structural bioinformatics, molecular simulation, and single-molecule FRET microscopy for observing the ligand-dependent conformational dynamics of integral membrane proteins in situ. We focus on representative members of the small monotopic phosphoglycosyl transferase (SmPGT) superfamily, which catalyze transfer of a phosphosugar from a soluble nucleotide-sugar donor to a membrane-embedded polyprenol phosphate acceptor in the initiating step of glycoconjugate biosynthesis in prokaryotes. Substrate-specific structural features were identified across the superfamily and correlated with ligand-dependent conformational dynamics in all-atom simulations. To experimentally validate the role of this motion in ligand binding, we developed a platform to monitor intra-molecular protein dynamics in a native-like lipid environment. The presented approach incorporates selective cysteine protein labeling and non-canonical amino acid mutagenesis with bicyclononyne-tetrazine click chemistry to assemble dual-labeled variants of PglC, the initiating enzyme of the N-linked protein glycosylation pathway from Campylobacter jejuni. The modified proteins are then solubilized into styrene maleic acid liponanoparticles (SMALPs) to maintain an in situ membrane environment. The conformational changes of PglC upon inhibitor binding are diagnostic of inhibitor potency. The single-molecule FRET-SMALP strategy can be adapted to investigate protein dynamics across the superfamily of SmPGTs with different substrate selectivity where structure prediction and molecular dynamics support significant conformational changes upon ligand binding. Broader Impact: Membrane protein structure-function relationships are critical for understanding fundamental biological processes and for the development of small-molecule drug treatments. Bacterial glycoconjugate biosynthesis pathways are a promising target for strain-specific antibiotics and exemplify the challenges of characterizing biomolecular systems that depend on highly specific protein, lipid, and carbohydrate chemistries. We integrate molecular simulation, structural bioinformatics, and single-molecule FRET to elucidate details of small-molecule binding to the PGT superfamily.

  • Open Access

    Proteome-wide bioinformatic annotation and functional validation of the monotopic phosphoglycosyl transferase superfamily

    by Theo Durand, Greg J. Dodge, Roxanne P. Siuda, Hugh R. Higinbotham, Christine A. Arbour, Soumi Ghosh, Karen N. Allen, Barbara Imperiali

    Phosphoglycosyl transferases (PGTs) are membrane proteins that initiate glycoconjugate biosynthesis by transferring a phospho-sugar moiety from a soluble nucleoside diphosphate sugar to a membrane-embedded polyprenol phosphate acceptor. The centrality of PGTs in complex glycan assembly and the current lack of functional information make these enzymes high-value targets for biochemical investigation. In particular, the small monotopic PGT family is exclusively bacterial and represents the minimal functional unit of the monotopic PGT superfamily. Here, we combine a sequence similarity network analysis with a generalizable, luminescence-based activity assay to probe the substrate specificity of this family of monoPGTs in the bacterial cell-membrane fraction. This strategy allows us to identify specificity on a far more significant scale than previously achievable and correlate preferred substrate specificities with predicted structural differences within the conserved monoPGT fold. Finally, we present the proof-of-concept for a small-scale inhibitor screen (eight nucleoside analogs) with four monoPGTs of diverse substrate specificity, thus building a foundation for future inhibitor discovery initiatives.


  • Dual Glycosyltransferases from Campylobacter concisus Diverge from the Canonical Campylobacter N-Linked Glycan Assembly Pathway

    by Christine A. Arbour, Nemanja Vuksanovic, Karen N. Allen, Barbara Imperiali

    Species within the Campylobacter genus are recognized as emerging human pathogens. Common to all known members of the genus is the presence of an asparagine-linked glycosylation pathway encoded by the pgl operon. Campylobacter species are divided into two major groups, Group I and Group II. To date, most biochemical studies have focused on the Group I species including Campylobacter jejuni. We recently reported that the Group II Campylobacter concisus pathway deviates from that of Group I by the inclusion of a C-6″-oxidized GalNAc (GalNAcA) at the third position installed by PglJ. Herein, we investigate the diversification of the PglH enzymes that act subsequent to installation of GalNAcA. The majority of pgl operons from Group II species, including C. concisus, encode two GT-B fold glycosyltransferases (GTs), PglH1 and PglH2. As the functions of these GTs were not clear by simple comparison of their sequences to that of C. jejuni PglH, further analyses were required. We show that subsequent to the action of PglJ, PglH2 installs the next HexNAc followed by PglH1 adding a single sugar. These steps diverge from the C. jejuni pathway not only in the identity of the sugar donors (UDP-GlcNAc) but also in installing single sugars rather than acting processively. These biochemical studies were extended via bioinformatics to identify sequence signatures that provide predictive capabilities for unraveling the prokaryotic glycan landscape. Phylogenetic analysis showed early divergence between the C. jejuni PglH orthologs and C. concisus PglH1/PglH2 orthologs, leading to diversification of the final glycan.


  • Open Access

    Proteome-Wide Bioinformatic Annotation and Functional Validation of the Monotopic Phosphoglycosyl Transferase Superfamily

    by Theo Durand, Greg J. Dodge, Roxanne P. Siuda, Hugh R. Higinbotham, Christine A. Arbour, Soumi Ghosh, Karen N. Allen, Barbara Imperiali

    Phosphoglycosyl transferases (PGTs) are membrane proteins that initiate glycoconjugate biosynthesis by transferring a phospho-sugar moiety from a soluble nucleoside diphosphate sugar to a membrane-embedded polyprenol phosphate acceptor. The centrality of PGTs in complex glycan assembly and the current lack of functional information make these enzymes high-value targets for biochemical investigation. In particular, the small monotopic PGT family is exclusively bacterial and represents the minimal functional unit of the monotopic PGT superfamily. Here, we combine a sequence similarity network (SSN) analysis with a generalizable, luminescence-based activity assay to probe the substrate specificity of this family of monoPGTs in a bacterial cell-membrane fraction. This strategy allows us to identify specificity on a far more significant scale than previously achievable and correlate preferred substrate with predicted structural differences within the conserved monoPGT fold. Finally, we present the proof-of-concept for a small-scale inhibitor screen (eight nucleoside analogs) with four monoPGTs of diverse substrate specificity, thus building a foundation for future inhibitor discovery initiatives. Significance Uncovering the enzymes responsible for glycoconjugate biosynthesis traditionally requires a multi-faceted and individually curated approach. This is especially true for bacterial glycoconjugates due to greater monosaccharide diversity and a paucity of established structural information. Here we leverage bioinformatic and in-vitro tools to predict and validate substrate specificity for a unique, exclusively bacterial family of enzymes responsible for the first step in many of these glycan assembly pathways. We further show that our platform is suitable for enhanced functional annotation and inhibitor testing, paving the way for the development of urgently needed antibiotics.


  • Characterization of PglJ, a Glycosyltransferase in the Campylobacter concisus N-Linked Protein Glycosylation Pathway that Expands Glycan Diversity

    by Christine A. Arbour, Nemanja Vuksanovic, Hannah M. Bernstein, Karen N. Allen, Barbara Imperiali

    The Campylobacter genus of Gram-negative bacteria is characterized by the expression of N-linked protein glycosylation (pgl) pathways. As Campylobacter concisus is an emerging human pathogen, a better understanding of the variation of the biosynthetic pathways across the genus is necessary to identify the relationships between protein glycosylation and disease. The pgl pathways of C. concisus strains have been reported to diverge from other Campylobacter in steps after the biosynthesis of N-acetylgalactosamine-α1,3-N,N'-diacetylbacillosamine-α-1-diphosphate undecaprenyl (GalNAc-diNAcBac-PP-Und), which is catalyzed by PglC and PglA, a phosphoglycosyltransferase (PGT) and a glycosyltransferase (GT), respectively. Here we characterize the PglJ GTs from two strains of C. concisus. Chemical synthesis was employed to access the stereochemically defined glycan donor substrates, uridine diphosphate N-acetyl-d-galactosaminuronic acid (UDP-GalNAcA) and uridine diphosphate N-acetyl-d-glucosaminuronic acid (UDP-GlcNAcA), to allow biochemical investigation of PglJ. Evidence for the PglJ substrate specificity structural determinants for the C6″ carboxylate-containing sugar was obtained through variant-based biochemical assays. Additionally, characterization of a UDP-sugar dehydrogenase encoded in the pgl operon, which is similar to the Pseudomonas aeruginosa WbpO responsible for the oxidization of a UDP-HexNAc to UDP-HexNAcA, supports the availability of a UDP-HexNAcA substrate for a GT that incorporates the modified sugar and provides evidence for the presence of a HexNAcA in the N-linked glycan. Utilizing sequence similarity network (SSN) analysis, we identified conserved sequence motifs among PglJ glycosyltransferases, shedding light on substrate preferences and offering predictive insights into enzyme functions across the Campylobacter genus. These studies now allow detailed characterization of the later steps in the pgl pathway in C. concisus strains and provide insights into enzyme substrate specificity determinants for glycan assembly enzymes.


  • Open Access

    Defining early steps in Bacillus subtilis biofilm biosynthesis

    by Christine A. Arbour, Rupa Nagar, Hannah M. Bernstein, Soumi Ghosh, Yusra Al-Sammarraie, Helge C. Dorfmueller, Michael A. J. Ferguson, Nicola R. Stanley-Wall, Barbara Imperiali

    The Bacillus subtilis extracellular biofilm matrix includes an exopolysaccharide (EPS) that is critical for the architecture and function of the community. To date, our understanding of the biosynthetic machinery and the molecular composition of the EPS of B. subtilis remains unclear and incomplete. This report presents synergistic biochemical and genetic studies built from a foundation of comparative sequence analyses targeted at elucidating the activities of the first two membrane-committed steps in the EPS biosynthetic pathway. By taking this approach, we determined the nucleotide sugar donor and lipid-linked acceptor substrates for the first two enzymes in the B. subtilis biofilm EPS biosynthetic pathway. EpsL catalyzes the first phosphoglycosyl transferase step using uridine diphosphate (UDP)-di- N -acetyl bacillosamine as phospho-sugar donor. EpsD is a predicted GT-B fold (GT4 family) retaining glycosyl transferase that catalyzes the second step in the pathway that utilizes the product of EpsL as an acceptor substrate and UDP- N -acetyl glucosamine as the sugar donor. Thus, the study defines the first two monosaccharides at the reducing end of the growing EPS unit. In doing so, we provide the first evidence of the presence of bacillosamine in an EPS synthesized by a Gram-positive bacterium. IMPORTANCE: Biofilms are the communal way of life that microbes adopt to increase survival. Key to our ability to systematically promote or ablate biofilm formation is a detailed understanding of the biofilm matrix macromolecules. Here, we identify the first two essential steps in the Bacillus subtilis biofilm matrix exopolysaccharide (EPS) synthesis pathway. Together, our studies and approaches provide the foundation for the sequential characterization of the steps in EPS biosynthesis, using prior steps to enable chemoenzymatic synthesis of the undecaprenyl diphosphate-linked glycan substrates.


  • Deploying solid-phase synthesis to access thymine-containing nucleoside analogs that inhibit DNA repair nuclease SNM1A

    by Christine A. Arbour, Ellen M. Fay, Joanna F. McGouran, Barbara Imperiali

    Nucleoside analogs show useful bioactive properties. A versatile solid-phase synthesis that readily enables the diversification of thymine-containing nucleoside analogs is presented. The utility of the approach is demonstrated with the preparation of a library of compounds for analysis with SNM1A, a DNA damage repair enzyme that contributes to cytotoxicity. This exploration provided the most promising nucleoside-derived inhibitor of SNM1A to date with an IC50 of 12.3 μM.